Skip to Main Content
Back to News

Insider Sale: Chief R&D Officer of $NKTR (NKTR) Sells 7,785 Shares

None

Jonathan Zalevsky, the Chief R&D Officer of $NKTR ($NKTR), sold 7,785 shares of the company on 11-19-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.1% of their shares. Following this trade, they now own 243,019 shares of $NKTR stock.

$NKTR Insider Trading Activity

$NKTR insiders have traded $NKTR stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $NKTR stock by insiders over the last 6 months:

  • JONATHAN ZALEVSKY (Chief R&D Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 14,651 shares.
  • MARK ANDREW WILSON (Chief Legal Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 12,058 shares.
  • HOWARD W ROBIN (President & CEO) has traded it 2 times. They made 0 purchases and 2 sales, selling 31,159 shares.
  • ROBERT CHESS sold 19,500 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$NKTR Hedge Fund Activity

We have seen 60 institutional investors add shares of $NKTR stock to their portfolio, and 70 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles